Hangzhou Tigermed Consulting Co., Ltd
HNGZY
$3.96
-$0.14-3.38%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 257.99M | 223.37M | 215.04M | 195.52M | 247.52M |
| Total Other Revenue | -9.93M | 9.83M | -- | 17.94M | -8.74M |
| Total Revenue | 248.05M | 233.21M | 215.04M | 213.46M | 238.78M |
| Cost of Revenue | 179.92M | 162.92M | 150.46M | 175.37M | 149.76M |
| Gross Profit | 68.13M | 70.28M | 64.58M | 38.09M | 89.01M |
| SG&A Expenses | 33.86M | 34.65M | 33.03M | 31.47M | 32.75M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -2.10M | 2.79M | -808.30K | -25.90K | 507.60K |
| Total Operating Expenses | 220.66M | 209.76M | 190.81M | 216.03M | 189.65M |
| Operating Income | 27.40M | 23.45M | 24.24M | -2.57M | 49.13M |
| Income Before Tax | 108.99M | 41.36M | 19.75M | -58.75M | 55.45M |
| Income Tax Expenses | 7.16M | 6.39M | 4.63M | 4.55M | 7.18M |
| Earnings from Continuing Operations | 101.83M | 34.97M | 15.12M | -63.29M | 48.27M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -12.82M | -4.84M | 7.63M | 6.54M | -3.49M |
| Net Income | 89.01M | 30.13M | 22.75M | -56.76M | 44.78M |
| EBIT | 27.40M | 23.45M | 24.24M | -2.57M | 49.13M |
| EBITDA | 34.57M | 30.68M | 31.29M | 4.56M | 55.60M |
| EPS Basic | 0.10 | 0.04 | 0.03 | -0.07 | 0.05 |
| Normalized Basic EPS | 0.02 | 0.03 | 0.03 | 0.01 | 0.03 |
| EPS Diluted | 0.10 | 0.04 | 0.03 | -0.07 | 0.05 |
| Normalized Diluted EPS | 0.02 | 0.03 | 0.03 | 0.01 | 0.03 |
| Average Basic Shares Outstanding | 868.80M | 832.83M | 870.89M | 856.11M | 866.76M |
| Average Diluted Shares Outstanding | 868.80M | 832.83M | 870.89M | 856.11M | 866.76M |
| Dividend Per Share | -- | -- | -- | 0.04 | -- |
| Payout Ratio | 10.93% | 112.20% | 16.35% | -8.16% | 169.91% |